Predictors of long-term response to protease inhibitor therapy in a cohort of HIV-infected patients
- 1 July 1998
- journal article
- research article
- Published by Wolters Kluwer Health in AIDS
- Vol. 12 (11) , F131-F135
- https://doi.org/10.1097/00002030-199811000-00005
Abstract
To assess the rate of long-term effectiveness and factors associated with response to protease inhibitor therapy in a cohort of HIV-infected patients.Keywords
This publication has 10 references indexed in Scilit:
- Virological treatment failure of protease inhibitor therapy in an unselected cohort of HIV-infected patientsAIDS, 1997
- Treatment with Indinavir, Zidovudine, and Lamivudine in Adults with Human Immunodeficiency Virus Infection and Prior Antiretroviral TherapyNew England Journal of Medicine, 1997
- A Controlled Trial of Two Nucleoside Analogues plus Indinavir in Persons with Human Immunodeficiency Virus Infection and CD4 Cell Counts of 200 per Cubic Millimeter or LessNew England Journal of Medicine, 1997
- Antiretroviral Therapy for HIV Infection in 1997JAMA, 1997
- Antiretroviral Therapy for HIV Infection in 1996JAMA, 1996
- SaquinavirDrugs, 1996
- HIV-1 RNA levels and the development of clinical diseaseAIDS, 1996
- Prognosis in HIV-1 Infection Predicted by the Quantity of Virus in PlasmaScience, 1996
- A Preliminary Study of Ritonavir, an Inhibitor of HIV-1 Protease, to Treat HIV-1 InfectionNew England Journal of Medicine, 1995
- In vivo emergence of HIV-1 variants resistant to multiple protease inhibitorsNature, 1995